Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
about
The role of medications in causing dry eyeThe management of glaucoma and intraocular hypertension: current approaches and recent advancesA 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients.Patient persistence with first-line antiglaucomatous monotherapy.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionProstamides (prostaglandin-ethanolamides) and their pharmacology.Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical settingLate-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials.Patterns of opioid analgesic prescription among patients with osteoarthritis.Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.Clinical pharmacology of bimatoprost.Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies.Fixed-combination and emerging glaucoma therapies.Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model.Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patientsPaired-eye comparison of medical therapies for glaucoma.Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications.A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost.A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure.Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.
P2860
Q21296673-904D99B3-7395-4700-8A0A-AFBA44E65830Q22305849-9C434DCF-5C62-408E-96EF-AE974E0E154FQ33226133-229F3F56-AFC1-4835-B7E2-4208AAC72BC7Q33819822-42491D0E-1A52-4308-8D32-F3BFB4CF8F5BQ34043309-20D0A236-D4E8-41E5-925B-8A416C505487Q34667670-2F43ED2F-E194-400D-AE8C-E6394306B0D8Q34901153-E62A803C-B16A-4F10-8837-29E95BAC2F20Q34981213-CA371804-0475-4BE5-B942-04E711CAF857Q35050234-003C3B4D-605F-4AC5-876D-71F742638D82Q35775628-01311558-6AB4-40AB-90A4-222EDFC6BEADQ36134942-A94F0E89-1AC3-44D5-9D1A-D7FF8EF363E6Q36572646-20B27E16-C39F-4D7A-B239-3217AC50C5FCQ36856440-CBFA2882-4A0A-4728-ADB7-D501416C3BA2Q36866626-FD338993-D64F-4D90-90B7-2E682EE038FAQ36920000-8F851007-34E9-4215-A5D2-8CC9E892F5A4Q37697869-F47FEE64-7313-4AD7-9A2C-14606FE64BB6Q37801282-C77413F8-E3AA-4B5B-B0B7-B9DEF499C903Q39506959-81253318-0A11-4A65-9D36-71E511B5835DQ42029736-EDB08969-CC93-4C0A-B471-4CD48640A424Q42280470-4C665300-66CA-4E2F-9A63-24705283545EQ44637557-C96C2C38-4AD4-446F-8176-5B8EAFB7C265Q45462727-603301B6-2739-4BB5-A873-A4AB93481698Q52995234-BCCCEDD7-19A3-440F-BBB4-CFEF59D41C2A
P2860
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Two-year double-masked compari ...... aucoma or ocular hypertension.
@en
Two-year double-masked compari ...... aucoma or ocular hypertension.
@nl
type
label
Two-year double-masked compari ...... aucoma or ocular hypertension.
@en
Two-year double-masked compari ...... aucoma or ocular hypertension.
@nl
prefLabel
Two-year double-masked compari ...... aucoma or ocular hypertension.
@en
Two-year double-masked compari ...... aucoma or ocular hypertension.
@nl
P2093
P1476
Two-year double-masked compari ...... aucoma or ocular hypertension.
@en
P2093
Amanda M VanDenburgh
Janet K Cheetham
John S Cohen
Paula Bernstein
Ronald L Gross
P304
P356
10.1016/J.SURVOPHTHAL.2003.12.019
P478
49 Suppl 1
P577
2004-03-01T00:00:00Z